StockData
BioStem Technologies, Inc. logo

BioStem Technologies, Inc. (BSEM) stock

BSEMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$0.64−0.07 (-10.23%)

Close on Nov 20, 2026Market cap $11.34MP/E –Yield –

BioStem Technologies price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

No price to sales ratio figures for BioStem Technologies

BioStem Technologies has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More BioStem Technologies figures

See a number that looks wrong?